We cannot keep relying on company reputation to stand out; we need to be smart, agile and personalised. The data says so.
Let’s be honest, the future of the Pharmaceutical Industry lies in overcoming barriers to innovation through data analytics optimisation. We need to move past the challenge of unstructured data sets and integrating data from multiple sources to begin to work collaboratively with other departments and organisations and create a real world evidence framework for our pharmaceutical development through effective data utilisation.
This November, industry leaders from key pharma companies like Janssen, Purdue, AstraZeneca, Novo Nordisk & GSK will be sharing their insights into the role of data analytics, discussing tangible method for data optimisation, and translating this into real world strategies for your company.
Are you an Industry Innovator trying to advance your company’s data utilisation? Are you intent on maximizing your analytical capabilities and value, but unsure of your next steps? We all know that Data Analytics, or ‘Big Data’ is not new to the Industry, but this year’s Data Analytics in Pharma Development forum will ensure that you are at the forefront of innovative industry discussion and process excellence strategies.